CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Endo Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Endo Inc
1400 Atwater Drive
Phone: (484) 216-0000p:484 216-0000 MALVERN, PA  19355  United States Ticker: NDOINDOI
On 4/23/2024, Endo, Inc., a newly formed entity, announced that it successfully completed the previously announced acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's plan of reorganization.
Business Summary
Endo, Inc. is a diversified specialty pharmaceutical company, which is engaged in transforming insights into life-enhancing therapies. The Company’s segments include Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Its Branded Pharmaceuticals segment focuses on products that have inherent scientific, regulatory, legal and/or technical complexities and are marketed under recognizable brand names that are trademarked. Its Sterile Injectables segment includes a broad portfolio of approximately 40 critical care, maternal health, anesthesia and other products. Its Generic Pharmaceuticals segment includes a portfolio of approximately 85 generic product families, including solid oral extended-release products, solid oral immediate release products, liquids, semi-solids, and others. Its International Pharmaceuticals segment sells a variety of specialty pharmaceutical products outside the United States, primarily to customers in Canada.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President/CEO BlaiseColeman
Independent Chairman of the Board PaulHerendeen 68 4/23/2024 4/23/2024
President, Chief Executive Officer, Director Blaise A.Coleman 50
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Astora Women's Health Ireland Limited First Floor, Minerva House Ballsbridge Ireland
Endo Eurofin Unlimited Company First Floor, Minerva House Ballsbridge Ireland
Endo Global Biologics Limited First Floor, Minerva House Dublin Ireland
45 additional Subsidiary records available in full report.

Business Names
Business Name
0Y5F
70 Maple Avenue, LLC
Actient Pharmaceuticals LLC
121 additional Business Names available in full report.

General Information
Number of Employees: 2,995 (As of 5/31/2024)
Outstanding Shares: 76,400,000 (As of 7/25/2024)
Stock Exchange: OTC
Federal Tax Id: 301390281
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024